scout

Podcasts

Recent Episodes

Presenting investigators at ESMO Congress 2025 highlight findings from clinical trials assessing novel therapeutics across different disease types.
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
“Paradigm-changing events” are occurring across the small cell lung cancer field in real time, according to Anne Chiang, MD, PhD.
Leveraging Biology to Advance the Small Cell Lung Cancer Treatment Paradigm
Experts highlight anticipated sessions at the 2025 ESMO Congress, including those on the PSMAddition and EV-303 trials.
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
Jorge Cortes, MD, outlines the impact of imatinib in chronic myeloid leukemia and highlights future initiatives in the field.
Charting the Evolution of TKIs and Finding the Next Breakthrough in CML
A panel of oncology pharmacists discusses the role of lifileucel in metastatic melanoma and other considerations for using cellular therapy in solid tumors.
Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid Tumors
Prospective data observed with the gemcitabine intravesical system may be superior to prior reports of other therapies in BCG-unresponsive NMIBC.
Gemcitabine Intravesical System Offers Tremendous Benefits in NMIBC
Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.
Diving Into the Practical Applications of ctDNA in Oncology Care
How to Discuss Death: A Conversation of Mortality in Cancer Care
How to Discuss Death: A Conversation of Mortality in Cancer Care
Panelists and presenters attending World GU 2025 shared their perspectives on optimizing the management of prostate, kidney, and bladder cancers.
Episode 14: Multidisciplinary Care Insights Across World GU 2025
Experts detailed key advances in myelofibrosis, multiple myeloma, and lymphoma at the Society of Hematologic Oncology 2025 Annual Meeting.
Unraveling Key Blood Cancer Takeaways From the 2025 SOHO Meeting

All series

Presenting investigators at ESMO Congress 2025 highlight findings from clinical trials assessing novel therapeutics across different disease types.

Recent Episodes

A panel of oncology pharmacists discusses the role of lifileucel in metastatic melanoma and other considerations for using cellular therapy in solid tumors.

Oncology On the Go With ASTCT Talks

Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.

ONCOLOGY Decoded

Prospective data observed with the gemcitabine intravesical system may be superior to prior reports of other therapies in BCG-unresponsive NMIBC.

FDA Approval Alert: The Need-to-Know

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO

Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us